Raze Therapeutics

About:

Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.

Website: http://www.razetx.com/

Twitter/X: razetx

Top Investors: Novartis, Atlas Venture, M Ventures, MPM Capital, Astellas Venture Management

Description:

Raze Therapeutics is leading the discovery and development of a new class of oncology therapeutics that target key metabolic pathways. Raze is advancing a pipeline of therapeutics based on new biological insights into how cancer cells reprogram metabolism to activate central anabolic processes essential for tumors to grow and survive.

Total Funding Amount:

$24M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)razetx.com

Founders:

David Sabatini, Joshua Rabinowitz, Vamsi Mootha

Number of Employees:

1-10

Last Funding Date:

2014-10-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai